FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to introducing dairy fat or an analogue thereof, optionally with at least one additional therapeutic factor, preferentially with lactoferrin or lactoferrin containing a metal ion, preferentially lactoferrin containing iron, preferentially bovine lactoferrin containing iron or a functional version thereof containing metal ions or a functional fragment to inhibit the tumour formation or growth, to maintain or improve one or more parameters, such as leukocyte count, erythrocyte count, or myelocyte count, to reduce the manifestations of cachexia, mucositis and anemia, to stimulate the immune system and to treat or prevent a malignancy and malignant symptoms, and side effects of treating the malignant tumour. Methods and therapeutic use according to the invention may be implemented by the use of a diet (in the form of food products or food additives), nutrient or pharmaceutical composition. There are also presented compositions applicable in the methods according to the invention.
EFFECT: group of inventions provides the higher clinical effectiveness or prevention of the malignant tumour or its symptoms.
39 cl, 7 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTICS AND TREATMENT OF MALIGNANT TUMOURS OF PANCREAS, OVARIES AND OTHER MALIGNANT TUMOURS | 2009 |
|
RU2556129C2 |
METHOD FOR THERAPY OF MALIGNANT TUMOUR | 2011 |
|
RU2577993C2 |
MONOCLONAL ANTIBODIES FOR TUMOUR TREATMENT | 2009 |
|
RU2531758C2 |
IMPROVED METHODS FOR TREATING TUMOURS | 2007 |
|
RU2481853C2 |
SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
DRUG AND COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS | 2017 |
|
RU2777595C2 |
METHOD OF TREATING MALIGNANT TUMOUR | 2020 |
|
RU2816126C2 |
USE OF PARASITES AND EXTRACELLULAR VESICLES DERIVED FROM PARASITES FOR TREATING MALIGNANT TUMOUR | 2020 |
|
RU2814990C2 |
COMBINATION OF ANTI-PD-L1 ANTIBODY AND DNA-PK INHIBITOR FOR TREATING MALIGNANT NEOPLASM | 2018 |
|
RU2765997C2 |
TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
Authors
Dates
2013-06-10—Published
2008-05-14—Filed